FDA says Moderna vaccine's benefits outweigh risks after Nordic countries limit use

The U.S. Food and Drug Administration reiterated its stance that the benefits of Moderna’s COVID-19 vaccine outweigh its risks on Friday after several Nordic countries began restricting its use for certain age groups due to concerns about a rare heart-related side effect.